Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 3, 2011, Pages 651-658

  Mankhatitham, Wiroj ^a   Lueangniyomkul, Aroon ^a   Manosuthi, Weerawat ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Hepatotoxicity; NNRTI based ART; RMP; TB HIV 1 co infected patients

Indexed keywords

EID: 79961059937     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Breen RAM, Miller RF, Gorsuch T, et al. Adverse event and treatment interruption in tuberculosis patients with and without HIV co-infectionThorax 2006; 1: 791-4. (Pubitemid 44369404)
2. Ena J, Amador C, Benito C, Fenoll V, Pasquau F. Risk and determinants of developing severe liver toxicity during therapy with nevirapine - and efavirenz- containing regimens in HIV-infected patientsInt J STD AIDS 2003; 14: 776-81. (Pubitemid 37372234)
3. nd ed. Geneva: World Health Organization, 2004.
4. Jain MK. Drug-induced liver injury associated with HIV medicationClin Liver Dis 2007; 11: 625-39.
5. Krittiyanant S, Sakulbamrungsil R, Wongwiwatthananukit S, Suthiputthanangoon W. Risk factors of antituberculosis druginduced hepatotoxicity in Thai patientsThai J Pharm Sci 2002; 26:121-8.
6. Law WP, Dore GJ, Duncombe CJ, et al. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001AIDS 2003; 17:2191-9. (Pubitemid 37338892)
7. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors for mortality among HIV/tuberculosis- co-infected patients with and without antiretroviral therapyJ AIDS 2006; 43:42-6. (Pubitemid 44306486)
8. 2R study. Clin Infect Dis 2009; 48:1752-9.
9. Moses M, Zachariah R, Tayler-Smith K, et al. Outcomes and safety of concomitant nevirapine and rifampicin treatment under programmed condition in MalawiInt J Tuberc Lung Dis 2010; 14:197-202.
10. Ozick LA, Jacob L, Corner GM, et al. Hepatotoxicity from isoniazid and rifampicin in inner-city AIDS patientsAm J Gastroenterol 1995; 90:1978-80.
11. Pukenyte E, Lescure FX, Rey D, et al. Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentInt J Tuberc Lung Dis 2007; 11: 78-84. (Pubitemid 46101850)
12. Rivero A, Mira JA, Pineda JA. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitorsJ Antimicrob Chemother 2007; 59: 342-6. (Pubitemid 47073440)
13. Sathia L, Obiorah I, Taylor G, et al. Concomitant use of nonnucleoside analogue reverse transcriptase inhibitors and rifampicin in TB/HIV typel-coinfected patientsAIDS Res Hum Retroviruses 2008; 24:897-901.
14. Shipton LK, Westor CW, Stock S, et al. Safety and efficacy of nevirapine- and efavirenzbased antiretroviral treatment in adults treated for TB-HIV co-infection in BotswanaInt J Tuberc Lung Dis 2009; 13: 360-6.
15. Sulkowski MS, Thomas DI, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000; 283: 74-80. (Pubitemid 30038386)
16. Sulkowski MS, Thomas DL, Mehta SH, et al. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of Hepatitis C and B infections. Hepatology 2002; 35:182-9. (Pubitemid 34032559)
17. Ungo JR, Jones D, AShkin D, et al. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virusAm J Respir Crit Care Med 1998; 157:1871-6. (Pubitemid 28311273)
18. Varma JK, Nateniyom S, Akksilp S, et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational studyBMC Infect Dis 2009; 9: 42.
19. Yanai H, Uthaivoravit W, Panich V, et al. Rapid increase in HIV related tuberculosis, Chiang Rai, Thailand, 1990-1994AIDS 1996; 10: 527-31. (Pubitemid 26138659)